Amos, M.
and Bridges, A.
(2005),
Standards for Autoantibody Testing: Addressing Future Needs for Autoimmune Disease and Cancer Diagnosis, Cancer Biomarkers
(Accessed December 26, 2024)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Standards for Autoantibody Testing: Addressing Future Needs for Autoimmune Disease and Cancer Diagnosis
Published
Author(s)
, A.J. Bridges
Abstract
It is widely held that determination of increased levels of serum autoantibodies can play an important role in the diagnosis and, in some cases, management of many autoimmune diseases. It is also widely held that such testing is fraught with problems relating to accuracy and detection of clinically relevant autoantibodies. Attempts to standardize autoantibody testing by making available standard reference sera, have helped to some degree to improve the testing. Nevertheless, problems still exist and may be causing the delayed diagnosis of severely debilitating and sometimes fatal autoimmune diseases. This paper discusses current practice, as well as, possible new approaches intended to make more robust, autoantibody determinations in all fields of medicine.Citation
Cancer Biomarkers
Volume
1
Issue
4-5/2005
Pub Type
Journals
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.
Created December 17, 2005, Updated February 19, 2017